Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Carobene, Anna; Guerra, Elena; Locatelli, Massimo; Cucchiara, Vito; Briganti, Alberto; Aarsand, Aasne; Coskun, ABDURRAHMAN; Diaz-Garzon, Jorge; Fernandez-Calle, Pilar; Roraas, Thomas; Sandberg, Sverre; Jonker, Niels; Ceriotti, Ferruccio

doi:10.1016/j.cca.2018.07.043

Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer

Atıf İçin Kopyala

Carobene A., Guerra E., Locatelli M., Cucchiara V., Briganti A., Aarsand A. K. , et al.

CLINICA CHIMICA ACTA, cilt.486, ss.185-191, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 486
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.cca.2018.07.043
Dergi Adı: CLINICA CHIMICA ACTA
Sayfa Sayısı: ss.185-191

Özet

Background: Prostate-specific antigen (PSA) is central in the diagnosis of prostate cancer. However, high-quality biological variation (BV) estimates for PSA are scarce. Here BV estimates from the European Biological Variation Study (EuBIVAS) for total (tPSA), free (fPSA), conjugated PSA (cPSA), and percent free PSA (%fPSA) are provided.